Recombinant Mycobacterium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge.
about
Current status of vaccines for schistosomiasisApplications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapyDevelopment of the Brazilian Anti Schistosomiasis Vaccine Based on the Recombinant Fatty Acid Binding Protein Sm14 Plus GLA-SE AdjuvantCombined immunization using DNA-Sm14 and DNA-Hsp65 increases CD8+ memory T cells, reduces chronic pathology and decreases egg viability during Schistosoma mansoni infectionConstruction of EGFP-tagged rBCG of E.tenella and distribution in chickens.Evaluation of the Schistosoma mansoni Y-box-binding protein (SMYB1) potential as a vaccine candidate against schistosomiasis.A new recombinant BCG vaccine induces specific Th17 and Th1 effector cells with higher protective efficacy against tuberculosis.Manipulation of BCG vaccine: a double-edged sword.New Recombinant Mycobacterium bovis BCG Expression Vectors: Improving Genetic Control over Mycobacterial PromotersAntitumor effects of human interferon-alpha 2b secreted by recombinant bacillus Calmette-Guérin vaccine on bladder cancer cells.A vaccine consisting of Schistosoma mansoni cathepsin B formulated in Montanide ISA 720 VG induces high level protection against murine schistosomiasisProgress towards an HIV vaccine based on recombinant bacillus Calmette-Guérin: failures and challenges.A Combination of Recombinant Mycobacterium bovis BCG Strains Expressing Pneumococcal Proteins Induces Cellular and Humoral Immune Responses and Protects against Pneumococcal Colonization and Sepsis.Cross-species prophylactic efficacy of Sm-p80-based vaccine and intracellular localization of Sm-p80/Sm-p80 ortholog proteins during development in Schistosoma mansoni, Schistosoma japonicum, and Schistosoma haematobium.
P2860
Q24657733-96CB6468-7744-4094-AEF8-00143D06B949Q26798372-FA156DB9-05A8-49EE-97BC-A28A4CF8A85EQ26991992-9096BF31-4391-4BF3-B526-5CF970346F14Q30578697-DF474C4C-6225-4CC3-8D1E-FC7BE1F2B10BQ33419174-6A360FAD-7C90-4CD2-B4B5-5C627D25AF69Q33738522-95E92DF2-0239-4331-8AAC-36038631C76AQ34513982-C8DD9C77-5514-4BC5-908B-729B99F33834Q35904315-18ABBB3C-B5B4-4957-86BE-6ADA84B63EADQ35916250-EE87136B-92BA-4424-B889-5473D2A184C5Q35946382-1E997B26-2D1F-4BEA-A376-402A95ADCA6EQ35946661-BB7AA6D0-627D-4FB2-8E36-183170EBE4BAQ36690291-DEEE3BE4-09D0-42D6-B0FA-C9386F43DAF2Q40109570-F90BFE04-D059-46CF-BCBF-556DE9CAED78Q46287356-2F71204C-B250-4A4F-BFF7-2CD5F5F20FBE
P2860
Recombinant Mycobacterium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Recombinant Mycobacterium bovi ...... mice from cercarial challenge.
@ast
Recombinant Mycobacterium bovi ...... mice from cercarial challenge.
@en
Recombinant Mycobacterium bovi ...... mice from cercarial challenge.
@nl
type
label
Recombinant Mycobacterium bovi ...... mice from cercarial challenge.
@ast
Recombinant Mycobacterium bovi ...... mice from cercarial challenge.
@en
Recombinant Mycobacterium bovi ...... mice from cercarial challenge.
@nl
prefLabel
Recombinant Mycobacterium bovi ...... mice from cercarial challenge.
@ast
Recombinant Mycobacterium bovi ...... mice from cercarial challenge.
@en
Recombinant Mycobacterium bovi ...... mice from cercarial challenge.
@nl
P2093
P2860
P50
P1476
Recombinant Mycobacterium bovi ...... mice from cercarial challenge.
@en
P2093
Adriano S Campos
Denise C S Matos
Douglas McIntosh
Fabio I G Torres
Geraldo R G Armôa
Luciana C C Leite
Marilia S Almeida
Miriam Tendler
Mônica M Vilar
Paula B Varaldo
P2860
P304
P356
10.1128/IAI.72.6.3336-3343.2004
P407
P577
2004-06-01T00:00:00Z